Acotec Scientific Holdings (6669) Announces Approval for Microcatheter V-otter by PRC Authorities

Bulletin Express

Dec 03, 2025

Acotec Scientific Holdings Limited (Stock Code: 6669) received registration approval on December 1, 2025, from the PRC National Medical Products Administration for its Microcatheter V-otter. The device is designed for percutaneous interventional procedures in peripheral and coronary vasculature, including Transarterial Chemoembolization (TACE).

V-otter features a large-lumen design intended to prevent intraoperative catheter occlusion and offers three tip configurations—straight, 45° single-curve, and multi-curve—to accommodate vessels of various angles. The company intends to carry out marketing activities in the PRC market when deemed appropriate, noting that there is no guarantee of successful commercialization. Shareholders and potential investors are advised to exercise caution in dealing with the company’s shares.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1155221352"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1155221352\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1155221352?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-03 17:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1155221352","market":"us","top_or_hot":-1,"title":"Acotec Scientific Holdings (6669) Announces Approval for Microcatheter V-otter by PRC Authorities","media":"Bulletin Express","content":"<p>Acotec Scientific Holdings Limited (Stock Code: 6669) received registration approval on December 1, 2025, from the PRC National Medical Products Administration for its Microcatheter V-otter. The device is designed for percutaneous interventional procedures in peripheral and coronary vasculature, including Transarterial Chemoembolization (TACE).</p>\n<p>V-otter features a large-lumen design intended to prevent intraoperative catheter occlusion and offers three tip configurations—straight, 45° single-curve, and multi-curve—to accommodate vessels of various angles. The company intends to carry out marketing activities in the PRC market when deemed appropriate, noting that there is no guarantee of successful commercialization. Shareholders and potential investors are advised to exercise caution in dealing with the company’s shares.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Acotec Scientific Holdings (6669) Announces Approval for Microcatheter V-otter by PRC Authorities</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAcotec Scientific Holdings (6669) Announces Approval for Microcatheter V-otter by PRC Authorities\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-12-03 17:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Acotec Scientific Holdings Limited (Stock Code: 6669) received registration approval on December 1, 2025, from the PRC National Medical Products Administration for its Microcatheter V-otter. The device is designed for percutaneous interventional procedures in peripheral and coronary vasculature, including Transarterial Chemoembolization (TACE).</p>\n<p>V-otter features a large-lumen design intended to prevent intraoperative catheter occlusion and offers three tip configurations—straight, 45° single-curve, and multi-curve—to accommodate vessels of various angles. The company intends to carry out marketing activities in the PRC market when deemed appropriate, noting that there is no guarantee of successful commercialization. Shareholders and potential investors are advised to exercise caution in dealing with the company’s shares.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06669","symbol_name":"先瑞达医疗-B","start_time":0,"source_url":"","article_id":"1155221352","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1155221352","pubTimestamp":1764753136,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Acotec Scientific Holdings Limited (Stock Code: 6669) received registration approval on December 1, 2025, from the PRC National Medical Products Administration for its Microcatheter V-otter. The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06669":"先瑞达医疗-B"},"translate_title":"先瑞达科技(6669)宣布微导管V-otter获中国当局批准","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06669":1},"content_text":"Acotec Scientific Holdings Limited (Stock Code: 6669) received registration approval on December 1, 2025, from the PRC National Medical Products Administration for its Microcatheter V-otter. The device is designed for percutaneous interventional procedures in peripheral and coronary vasculature, including Transarterial Chemoembolization (TACE).\nV-otter features a large-lumen design intended to prevent intraoperative catheter occlusion and offers three tip configurations—straight, 45° single-curve, and multi-curve—to accommodate vessels of various angles. The company intends to carry out marketing activities in the PRC market when deemed appropriate, noting that there is no guarantee of successful commercialization. Shareholders and potential investors are advised to exercise caution in dealing with the company’s shares.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}